Neue verhaltenstherapeutische Verfahren in der Kopfschmerztherapie

Zusammenfassung

Zur Behandlung von Kopfschmerzen, insbesondere der Migräneerkrankung lassen sich neben medikamentösen Therapieoptionen auch nicht-medikamentöse Möglichkeiten erfolgreich einsetzen, die dem verhaltenstherapeutischen Methodenbereich entstammen. Hierzu gehören neben der Beratung und Führung des Patienten Entspannungstechniken, Biofeedback-Therapien und kognitive Verfahren. Die Zukunft der nicht-medikamentösen Kopfschmerztherapie kann in der Anwendung von Kurzzeitprogrammen mit minimalem Patientenkontakt gesehen werden sowie bei der Anwendung von Neurofeedback, wobei hier auch Verfahren mit Echtzeit-fMRI denkbar sind. Darüber hinaus sind Anwendungen der prä-emptiven Behandlung und spezifischer Desensibilisierungstechniken eventuell möglich.

Summary

Non-pharmacological treatment options in migraine and headache often originate from behaviorally oriented procedures. These consist of coaching of patients, of relaxation techniques, biofeedback strategies and cognitive-behavioral therapies. In future, minimal contact treatment programmes as well as neurofeedback including real-time fMRI may be possible. Additionally pre-emptive treatment schedules and desensitization techniques could be employed.

Schlüsselwörter

Kopfschmerz - Verhaltenstherapie - Biofeedback - prä-emptive Therapie - Desensibilisierung

Keywords

Headache - behavior therapy - biofeedback - pre-emptive treatment - desensitization

• Literatur

• 1 Andrasik F. Behavioral management of migraine. Biomedicine and Pharmacotherapy 1996; 50: 52-57.
• 2 Andrasik F. The essence of biofeedback, relaxation and hypnosis. In: Psychosocial aspects of pain: a Handbook for Healthcare Providers, Progress in Pain Research and Management. Dworkin RH, Breitbard WS. eds. Seattle: IASP Press; 2004. Vol 27; 285-305.
• 3 Basler HD, Franz C, Kröner-Herwig B, Rehfisch HP. Hrsg. Psychologische Schmerztherapie. Berlin, Heidelberg: Springer; 2004
• 4 Bischoff C, Traue HC. Kopfschmerzen. Göttingen: Hogrefe; 2004
• 5 Brune K, Diener HC, Evers S, Fritsche G, Kropp P, Limmroth V, May A, Pfaffenrath V, Straube A. Leitlinien Therapie der Migräneattacke und Migräneprophylaxe. In: Leitlinien für Diagnostik und Therapie in der Neurologie. Diener HC, Putzki N, Berlit P. (Hrsg). Stuttgart: Thieme; 2005. S. 494-508.
• 6 Campbell JK, Penzien DB, Wall EM. Evidencebased guidelines for migraine headaches: Behavioral and physical treatments. 2004 www.aan.com/public.
• 7 DeCharms RC, Maeda F, Glover GH, Ludlow D, Pauly JM, Soneji D, Gabrieli JD, Mackey SC. Control over brain activation and pain learned by using real-time functional MRI. Proc Natl Acad Sci USA 2005; 102: 18626-31.
• 8 Fernandez E, Boyle GJ. Affective and evaluative descriptors of pain in the McGill pain questionnaire: reduction and reorganization. Journal of Pain 2002; 03: 70-7.
• 9 French DJ, Holroyd KA, Pinell C, Malinoski PT, O´Donnell F, Hill KR. Perceived self-efficacy and headache-related disability. Headache 2000; 40: 647-56.
• 10 Gerber WD. Das Migräne-Patientenseminar MIPAS. Praxis-Magazin 2005; 21: 8-12.
• 11 Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J, Altman J, Goadsby PJ, Macrae A. Premonitory symptoms in migraine. Neurology 2003; 60: 935-40.
• 12 Grazzi L, Andrasik F, Dámico D, Leone M, Usai S, Kass SJ, Bussone G. Behavioral and pharmacological treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 2002; 42: 483-90.
• 13 Hay KM, Madders J. Migraine treated by relaxation therapy. Journal of the Royal Collegium of General Practice 1971; 21: 644-9.
• 14 Hermann C, Kim M, Blanchard EB. Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory metaanalysis. Pain 1995; 60: 239-56.
• 15 Hermann C, Blanchard EB. Biofeedback in the treatment of headache and other childhood pain. Applied Psychophysiology and Biofeedback 2002; 27: 143-62.
• 16 Holroyd KA, Andrasik F. A cognitive-behavioral approach to recurrent tension and migraine headache. In: Advances in Cognitive-Behavioral Research and Therapy. Kendall PC. (ed.). New York: Academic Press; 1982. Volume 1: 275-320.
• 17 Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004; 62: 788-90.
• 18 Kropp P, Gerber WD, Keinath-Specht A, Kopal T, Niederberger U. Behavioral treatment in migraine. Cognitive-behavioral therapy and blood-volume-pulse biofeedback: A cross-over study with a two-year follow-up. Functional Neurology 1997; 12: 17-24.
• 19 Kropp P, Siniatchkin M, Gerber WD. On the pathophysiology of migraine – links for “empirically based treatment” with neurofeedback. Applied Psychophysiology and Biofeedback 2002; 27: 203-13.
• 20 Kropp P, Linstedt U, Gerber WD. Die Dauer der Migräneerkrankung beeinflusst Amplitude und Habituation ereigniskorrelierter Potenziale. Der Schmerz 2005; 19: 489-96.
• 21 Kropp P, Gerber WD. Slow cortical potentials and migraine: predictive value and possible novel therapeutic strategies to prevent an attack. Functional Neurology 2005; 20: 193-7.
• 22 Martin PR, Reece J, Forsyth M. Noise as a trigger for headaches: relationship between exposure and sensitivity. Headache 2006; 46: 962-72.
• 23 Sargent JD, Green EE, Walters ED. Preliminary report on the use of autogenic feedback training in the treatment of migraine and tension headaches. Psychosomatic Medicine 1973; 35: 129-35.
• 24 Schoenen J. Neurophysiological features of the migrainous brain. Neurological Sciences 2006; 27: 77-81.
• 25 Schoonman GG, Evers DJ, Terwindt GM, van Dijk JG, Ferrari MD. The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients. Cephalalgia 2006; 26: 1209-13.
• 26 Speckenbach U, Gerber WD. Reliability of infrared plethysmography in BVP biofeedback therapy and the relevance for clinical application. Applied Psychophysiology and Biofeedback 1999; 24: 261-5.
• 27 Spitzer M. Therapie mit dem Scanner?. Nervenheilkunde 2006; 25: 390-2.
• 28 Tracey I, Ploghaus A, Gati JS, Clare S, Smith S, Menon RS, Matthews PM. Imaging attentional modulation of pain in the periaqueductal gray in humans. Journal of Neurosciences 2002; 22: 2748-52.
• 29 Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayk RV, Coenen HH, Diener HC. Brain stem activation in spontaneous human migraine attacks. Nature Medicine 1995; 01: 658-60.
• 30 Welch KM. Contemporary concepts in migraine pathogenesis. Neurology 2003; 28: 2-8.